Tudor Investment Corp ET AL cut its position in shares of Enovix Corporation (NASDAQ:ENVX – Free Report) by 42.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 342,952 shares of the company’s stock after selling 254,192 shares during the quarter. Tudor Investment Corp ET AL owned approximately 0.16% of Enovix worth $3,419,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Enovix by 5.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 98,318 shares of the company’s stock valued at $722,000 after buying an additional 4,780 shares during the period. NewEdge Advisors LLC raised its holdings in Enovix by 10.4% in the 1st quarter. NewEdge Advisors LLC now owns 26,257 shares of the company’s stock valued at $193,000 after acquiring an additional 2,481 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Enovix by 65.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company’s stock worth $8,351,000 after purchasing an additional 449,934 shares during the period. Caxton Associates LLP acquired a new stake in shares of Enovix during the first quarter worth $190,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Enovix by 18.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 358,023 shares of the company’s stock worth $2,628,000 after purchasing an additional 55,676 shares during the last quarter. Institutional investors and hedge funds own 50.92% of the company’s stock.
Enovix Stock Down 5.0%
ENVX opened at $5.12 on Friday. Enovix Corporation has a 1 year low of $4.61 and a 1 year high of $16.49. The firm has a 50 day moving average price of $5.99 and a 200 day moving average price of $8.24. The company has a debt-to-equity ratio of 1.90, a quick ratio of 8.13 and a current ratio of 8.34. The company has a market cap of $1.11 billion, a PE ratio of -6.65 and a beta of 2.15.
Analyst Ratings Changes
Read Our Latest Report on Enovix
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Featured Articles
Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Corporation (NASDAQ:ENVX – Free Report).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
